Prevention of Bacterial Infections in the Newborn by Pre-delivery Administration of Azithromycin (AZI): a Placebo-controlled Randomized Trial
Latest Information Update: 26 May 2020
At a glance
- Drugs Azithromycin (Primary)
- Indications Bacterial infections; Gram-positive infections; Neonatal infections
- Focus Therapeutic Use
- Acronyms PregnAnZI
- 23 May 2020 Results of post hoc analysis, evaluating the effect of intra-partum AZI on the prevalence of the macrolide resistance genes (msr(A) and ermC) in the nasopharynx at different time points during infancy, published in the Clinical Infectious Diseases
- 19 Aug 2019 Results describing bacterial population dynamics and resistance mechanism published in the Journal of Antimicrobial Chemotherapy
- 28 Mar 2018 Results (n=461) assessing long-term impact of oral azithromycin taken by gambian women during labour on prevalence and antibiotic susceptibility of s. pneumoniae and s. aureus in their infants: follow up of a randomized clinical trial were published in the Clinical Infectious Diseases.